Robert Bosch Venture Capital has exited Modcam after investing $600,000 in the computer vision sensor developer in 2015.

Losses at the commercialisation firm fell to $105m from $375m as its cash returns exceeded funding commitments for the first time in 13 years.

Axa Venture Partners led the $12m second close of a $22m round for AI-equipped sales intelligence platform developer Cognism.

Mitsubishi has reportedly elected to stop providing funding for the $1bn CVC partnership and Nissan to possibly follow.

George Health Enterprises and its subsidiary George Medicines have raised a combined $35m in funding from investors including Bupa Australia to drive pipeline development and commercialisation.

George Health Enterprises and its subsidiary George Medicines have raised a combined $35m in funding from investors including Bupa Australia to drive pipeline development and commercialisation.

Bristol Myers Squibb and Otsuka Pharmaceutical were among the limited partners for what LSP said is Europe's largest ever life sciences VC fund.

The Spain-based energy utility is set to contribute approximately $23m to the vehicle, which will invest in renewable energy technology developers.

The cancer immunotherapy developer has closed a $23.6m round featuring 3SBio Group and Eisai, both of which have signed collaboration agreements with it in recent months.

Rocket Internet-backed Goodlord has taken its total funding past $22m having raised more than $12.4m in a round led by venture firm Finch Capital.